Must the address on a drug label correspond to the place where the drug was manufactured?

• A. Yes, it must be the exact manufacturing facility address
• B. No, it can be the manufacturer's corporate headquarters
• C. It must be the country of origin only
• D. It must list only a post office box

Answer: (B)

The address on a drug label must identify the entity responsible for the product and provide a reliable way to contact them, not necessarily the exact place where it was manufactured. That means the label can list the manufacturer’s corporate headquarters as the address—as long as that corporate entity is the one legally responsible for the product's quality, safety, and regulatory compliance.

This helps regulators and consumers reach the company for recalls, adverse event reporting, or questions about the drug, even if production happens at multiple facilities. The key is clear accountability and a usable contact point, not a requirement that the label mirror a specific factory location.

So, selecting the corporate headquarters as the address is appropriate because it designates the responsible party and provides a central, publicly available point of contact. The exact manufacturing facility address isn’t required. The country of origin alone isn’t sufficient, and listing only a post office box typically doesn’t meet the need for a physical, traceable contact reference.